StonvexLoading…
StonvexStonvexStonvexCore line items from ORGO's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $564.17M | $482.04M | $433.14M | $450.89M |
Operating Income | $44.69M | $-1.28M | $12.53M | $22.30M |
Net Income | $37.03M | $861.00K | $4.95M | $15.53M |
EPS (Diluted) | $0.15 | $-0.01 | $0.04 | $0.12 |
Total Assets | $598.73M | $497.89M | $460.02M | $449.36M |
Total Liabilities | $164.81M | $112.57M | $181.36M | $183.69M |
Cash & Equivalents | $93.68M | $135.57M | $103.84M | $102.48M |
Free Cash Flow OCF − CapEx | $-24.46M | $4.18M | $6.55M | $-9.04M |
Shares Outstanding | 126.95M | 125.73M | 131.32M | 130.92M |